Good feedback from the curves on slide 7.
Important to see that expansion of the cohort by 20% has not changed the average wound size at each time point by much. Implies that the data variability is not large, hence greater chance of hitting a p-value.
The more I see from this very well designed trial, the more I like.
Ann: CEO Presentation to Bioshares Conference, page-6
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
